TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Palette Life Sciences AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 (consolidated) |
| Turnover |
100,283
|
61,859
|
338,969 |
| Financial expenses |
17,901
|
40,071
|
38,212 |
| Earnings before taxes |
4,373
|
-345,862
|
-307,836 |
| EBITDA |
22,306
|
-340,035
|
-267,808 |
| Total assets |
728,767
|
891,841
|
353,971 |
| Current assets |
78,341
|
78,770
|
243,569 |
| Current liabilities |
283,871
|
459,119
|
226,453 |
| Equity capital |
444,897
|
432,722
|
-134,226 |
| - share capital |
3,185
|
3,128
|
2,921 |
| Employees (average) |
2
|
2
|
84 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 (consolidated) |
| Solvency |
61.0%
|
48.5%
|
-37.9% |
| Turnover per employee |
50,142
|
30,930
|
4,035 |
| Profit as a percentage of turnover |
4.4%
|
-559.1%
|
-90.8% |
| Return on assets (ROA) |
3.1%
|
-34.3%
|
-76.2% |
| Current ratio |
27.6%
|
17.2%
|
107.6% |
| Return on equity (ROE) |
1.0%
|
-79.9%
|
229.3% |
| Change turnover |
37,309
|
-301,162
|
159,460 |
| Change turnover % | 59% | 89% | |
| Chg. No. of employees |
0
|
-82
|
35 |
| Chg. No. of employees % | 0% | 71% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.